Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study

被引：0

作者：

Lorenzo Iughetti

Gianluca Tornese

Maria Elisabeth Street

Flavia Napoli

Claudia Giavoli

Franco Antoniazzi

Stefano Stagi

Caterina Luongo

Sara Azzolini

Letizia Ragusa

Gianni Bona

Clara Zecchino

Tommaso Aversa

Luca Persani

Laura Guazzarotti

Emiliano Zecchi

Alberto Pietropoli

Stefano Zucchini

机构：

[1] University of Modena and Reggio Emilia,Pediatric Unit, Department of Medical and Surgical Sciences for Mother, Children and Adults

[2] Institute for Maternal and Child Health IRCCS Burlo Garofolo,Pediatric Unit

[3] Department of Paediatrics- Arcispedale S. Maria Nuova-IRCCS,Endocrinology and Metabolic Diseases Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico

[4] Istituto Giannina Gaslini,Pediatric Unit, Policlinico Giambattista Rossi

[5] Università degli Studi di Milano,Health Science Department, Anna Meyer Children’s University Hospital

[6] University of Verona,Department of Woman, Child and General and Specialized Surgery

[7] University of Florence,Pediatric Endocrinology Unit, Department of Woman’s and Child’s Health

[8] Seconda Università degli Studi di Napoli,Division of Paediatrics

[9] University Hospital of Padua,Department of Sciences and Pediatric Surgery

[10] UOC Pediatria,Department of Human Pathology of Adulthood and Childhood

[11] I.R.C.S.S. Oasi Maria SS,Department of Clinical Sciences and Community Health

[12] Azienda Ospedaliero-Universitaria Maggiore della Carità,Department of Paediatrics, Paediatric Endocrinology Unit

[13] University of Bari “A. Moro”,Unit of Pediatric Endocrinology

[14] University of Messina,undefined

[15] University of Milan,undefined

[16] Division of Endocrine and Metabolic Diseases,undefined

[17] IRCCS Istituto Auxologico Italiano,undefined

[18] University of Milan,undefined

[19] Sandoz S.p.A,undefined

[20] Hexal AG,undefined

[21] S.Orsola-Malpighi Hospital,undefined

来源：

Italian Journal of Pediatrics | / 42卷

关键词：

Adolescents; Children; Infants; Omnitrope®; Paediatric; Recombinant human growth hormone;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Safety and effectiveness of Omnitrope® in patients with growth hormone deficiency: snapshot analysis of PATRO Adults study in the Italian population
M. Arosio
G. Arnaldi
V. Gasco
C. Giavoli
E. Puxeddu
R. Vettor
M. R. Ambrosio
P. Gallinari
H. Zouater
P. Fedeli
D. Ferone
Journal of Endocrinological Investigation, 2021, 44 : 327 - 337
[22] PATRO children, a multi-center, non-interventional study of the safety and effectiveness of Omnitrope® (somatropin) treatment in children: update on the United States cohort
Backeljauw, Philippe
Miller, Bradley S.
Levy, Richard
McCormick, Kenneth
Zouater, Hichem
Zabransky, Markus
Campbell, Kim
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 34 (04): : 431 - 440
[23] Efficacy and safety of the treatment of growth hormone deficient children (GHD) with the recombinant hGH Omnitrope®: 84-month long-term data
Romer, Tomasz
Peter, Ferenc
Koehler, Brygida
Wasikowa, Renata
Walczak, Mieczyslaw
Korman, Eugeniusz
Starzyk, Jerzy
Berghout, Alexander
Zabransky, Markus
Saenger, Paul H.
HORMONE RESEARCH, 2009, 72 : 492 - 492
[24] Safety and effectiveness of Omnitrope® in patients with growth hormone deficiency: snapshot analysis of PATRO Adults study in the Italian population
Arosio, M.
Arnaldi, G.
Gasco, V
Giavoli, C.
Puxeddu, E.
Vettor, R.
Ambrosio, M. R.
Gallinari, P.
Zouater, H.
Fedeli, P.
Ferone, D.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (02) : 327 - 337
[25] No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study
Beck-Peccoz, Paolo
Hoybye, Charlotte
Murray, Robert D.
Simsek, Suat
Zabransky, Markus
Zouater, Hichem
Stalla, Guenter
BMC ENDOCRINE DISORDERS, 2019, 19 (01)
[26] No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study
Paolo Beck-Peccoz
Charlotte Höybye
Robert D. Murray
Suat Simsek
Markus Zabransky
Hichem Zouater
Günter Stalla
BMC Endocrine Disorders, 19
[27] Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy
Basmaison, Odile
Ranchin, Bruno
Zouater, Hichem
Robertson, Anna
Gomez, Roy
Koppiker, Nandan
ANNALES D ENDOCRINOLOGIE, 2019, 80 (04) : 202 - 210
[28] Efficacy and Safety of Long-Term Continuous Growth Hormone Treatment in Children with Prader-Willi Syndrome
van Wijngaarden, Roderick F. A. de Lind
Siemensma, Elbrich P. C.
Festen, Dederieke A. M.
Otten, Barto J.
van Mil, Edgar G. A. H.
Rotteveel, Joost
Odink, Roelof J. H.
Bindels-de Heus, G. C. B.
van Leeuwen, Mariettee
Haring, Danny A. J. P.
Bocca, Gianni
Houdijk, E. C. A. Mieke
Hoorweg-Nijman, J. J. Gera
Vreuls, Rene C. F. M.
Jira, Petr E.
van Trotsenburg, A. S. Paul
Bakker, Boudewijn
Schroor, Eelco J.
Pilon, Jan Willem
Wit, Jan M.
Drop, Stenvert L. S.
Hokken-Koelega, Anita C. S.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (11): : 4205 - 4215
[29] Efficacy and safety of long-term continuous growth hormone treatment of children born small for gestational age
Hokken-Koelega, A
van Pareren, Y
Arends, N
Boonstra, V
HORMONE RESEARCH, 2004, 62 : 149 - 154
[30] Safety and effectiveness of Omnitrope® (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data
Backeljauw, Philippe
Kanumakala, Shankar
Loche, Sandro
Schwab, Karl Otfried
Miller, Bradley S.
Levy, Richard
McCormick, Kenneth
Zouater, Hichem
Zabransky, Markus
Campbell, Kim
EUROPEAN JOURNAL OF PEDIATRICS, 2022, 181 (06) : 2367 - 2378

← 1 2 3 4 5 →